Our mission is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights from H&E image. By doing so, Imagene overcomes economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients.
Lawrence J. Ellison Institute for Transformative Medicine
"This is a breakthrough technology that has been tested in deep collaboration with the physicians of our pathology lab"
Sheba Medical Center
"We are proud to collaborate with Imagene and trust its potential to change the way we diagnose cancer patients."
Tel Aviv Sourasky Medical Center
"Cancer diagnosis focuses on pathological and molecular testing. I believe that no structure and assumptions should become a barrier to personal treatment. Imagene brings the potential of accurate, fast, actionable, standardized screening to all cancer patients."
Shaare Zedek Medical Center
“Our team is proud to be part of Imagene’s mission to leverage AI in the fight against cancer. The ongoing digitization of healthcare will reward medical providers, payers and patients with new ways of leveraging data to improve diagnoses, treatments and outcomes”
Blumberg Capital
"After seeing the same type of transformation in the AI medical imaging space, we are certain that Imagene is well positioned to disrupt the pathology biomarkers space with its unique AI platform and data assets.”
Making genomic testing accessible, leveraging the biopsy image for research and treatment optimization
Standardize, accelerate and reduce costs of drug development through deep learning for clinical trials
Supporting clinical decision-making by providing clinicians with a real-time molecular report using only the scanned image of an H&E-stained biopsy slide
lmagene's state-of-the-art deep learning models have the capabilities of searching for all present phenotypic alterations and empowering the reporting of meaningful insights.
We make no assumptions. our models rely on prospective data and unsupervised learning to provide the highest sensitivity and specificity rates.
“Imagene’s technology can unlock precise and crucial information in real-time, changing the way cancer is diagnosed and treated.”